Objective: The aim of this study was to investigate the effect of inhaled heparin on bronchoconstriction induced by ultrasonically nebulised distilled water (UNDW) in allergic asthmatics.

Methods: Eight atopic asthmatics, hyperresponsive to UNDW, were selected for this randomised, placebo-controlled, crossover double-blind study. On two consecutive days, these subjects underwent a UNDW challenge 45 min after inhaling aerosolised heparin (1000 U/kg) or placebo.

Results: Neither heparin nor placebo had a significant effect on base-line forced expiratory volume in 1 s (FEV1), but heparin significantly attenuated UNDW-induced bronchoconstriction, as shown by its efficacy in preventing the decreases in FEV1 produced by all doses of water (in comparison with placebo: P < 0.05 after 2 ml water; P < 0.01 after 4, 8 and 16 ml water).

Conclusion: Inhaled heparin is able to exert a protective effect against the bronchoconstrictive response to UNDW in allergic asthmatics, and this action is likely due to inhibition of mast cell degranulation.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s002280100262DOI Listing

Publication Analysis

Top Keywords

inhaled heparin
12
allergic asthmatics
8
undw allergic
8
heparin
5
heparin water-induced
4
water-induced bronchoconstriction
4
bronchoconstriction allergic
4
asthmatics objective
4
objective aim
4
aim study
4

Similar Publications

Heparin-azithromycin microparticles show anti-inflammatory effects and inhibit SARS-CoV-2 and bacterial pathogens associated to lung infections.

Carbohydr Polym

January 2025

Pharmaceutics and Food Technology Department, Faculty of Pharmacy, Universidad Complutense de Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; Instituto Universitario de Farmacia Industrial, Faculty of Pharmacy, Universidad Complutense de Madrid, 28040 Madrid, Spain. Electronic address:

Pulmonary infections are a leading cause of morbidity and mortality worldwide, a situation exacerbated by the COVID-19. Azithromycin (AZM) is used orally to treat pulmonary infections due to its ability to accumulate in lung tissues and immune cells after oral administration. Sulfated polysaccharides, such as heparin, are known to inhibit SARS-CoV-2 entry.

View Article and Find Full Text PDF

Molecular hydrogen (H) has antioxidant, anti-inflammatory, and anti-fibrotic effects. In a rat model simulating pulmonary fibrotic changes induced by monocrotaline-induced pulmonary hypertension (MPH), we had previously explored the impact of inhaled H on lung inflammation and blood pressure. In this study, we further focused the biological effects of H on mast cells (MCs) and the parameters of the fibrotic phenotype of the local tissue microenvironment.

View Article and Find Full Text PDF

Aim: To evaluate variations in diagnostic criteria and management recommendations for smoke inhalation injury (SII) amongst the burn networks of England, Scotland, and Wales.

Methods: A descriptive cross-sectional study examining SII guidelines provided by adult burn units and centres in England, Scotland and Wales.

Results: All 16 adult burn units and centres responded.

View Article and Find Full Text PDF

Severe pulmonary vasoconstriction induced by protamine is a rare complication. We report a case of a 77-year-old male patient with a history of mitral valve plasty (MVP). He underwent redo MVP via right thoracotomy under the totally endoscopic procedure (MICS redo-MVP).

View Article and Find Full Text PDF

Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy.

Acta Pharm Sin B

August 2024

Department of Pharmaceutics, Key Laboratory of Chemical Biology of Ministry of Education, School of Pharmaceutical Sciences, Cheelloo College of Medicine, Shandong University, Jinan 250012, China.

Article Synopsis
  • The study addresses the limitations of cuproptosis in treating lung metastasis due to low copper accumulation and an immunosuppressive tumor environment.
  • An inhalable nanodevice (CLDCu) is designed to enhance cuproptosis by efficiently delivering copper and disulfiram directly to lung lesions, significantly increasing drug accumulation compared to traditional intravenous methods.
  • CLDCu not only promotes cuproptosis in tumor cells but also activates the STING pathway to enhance immune response, leading to improved antitumor immunity when combined with anti-PD-L1 therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!